BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 10490030)

  • 1. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
    Wiesmann C; Ultsch MH; Bass SH; de Vos AM
    Nature; 1999 Sep; 401(6749):184-8. PubMed ID: 10490030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC.
    Ultsch MH; Wiesmann C; Simmons LC; Henrich J; Yang M; Reilly D; Bass SH; de Vos AM
    J Mol Biol; 1999 Jul; 290(1):149-59. PubMed ID: 10388563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor.
    Kullander K; Ebendal T
    J Neurosci Res; 1994 Oct; 39(2):195-210. PubMed ID: 7837289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor.
    Holden PH; Asopa V; Robertson AG; Clarke AR; Tyler S; Bennett GS; Brain SD; Wilcock GK; Allen SJ; Smith SK; Dawbarn D
    Nat Biotechnol; 1997 Jul; 15(7):668-72. PubMed ID: 9219271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational studies of conserved residues in the dimer interface of nerve growth factor.
    Guo M; Meyer SL; Kaur H; Gao JJ; Neet KE
    Protein Sci; 1996 Mar; 5(3):447-55. PubMed ID: 8868481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor induces a multimeric TrkA receptor complex in neuronal cells that includes Crk, SHC and PLC-gamma 1 but excludes P130CAS.
    Torres M; Bogenmann E
    Oncogene; 1996 Jan; 12(1):77-86. PubMed ID: 8552402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity determinants in neurotrophin-3 and design of nerve growth factor-based trkC agonists by changing central beta-strand bundle residues to their neurotrophin-3 analogs.
    Urfer R; Tsoulfas P; O'Connell L; Presta LG
    Biochemistry; 1997 Apr; 36(16):4775-81. PubMed ID: 9125498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75.
    He XL; Garcia KC
    Science; 2004 May; 304(5672):870-5. PubMed ID: 15131306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological determinants of nerve growth factor involved in p140trk (Trk) receptor binding.
    Nanduri J; Vroegop SM; Buxser SE; Neet KE
    J Neurosci Res; 1994 Mar; 37(4):433-44. PubMed ID: 7517456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75.
    Casaccia-Bonnefil P; Carter BD; Dobrowsky RT; Chao MV
    Nature; 1996 Oct; 383(6602):716-9. PubMed ID: 8878481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
    Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
    Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde axonal transport and lesion-induced upregulation of the TrkA high-affinity NGF receptor.
    Loy R; Lachyankar MB; Condon PJ; Poluha DK; Ross AH
    Exp Neurol; 1994 Dec; 130(2):377-86. PubMed ID: 7532592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cell death by endogenous nerve growth factor through its p75 receptor.
    Frade JM; Rodríguez-Tébar A; Barde YA
    Nature; 1996 Sep; 383(6596):166-8. PubMed ID: 8774880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and structure of the nerve growth factor binding site on TrkA.
    Robertson AG; Banfield MJ; Allen SJ; Dando JA; Mason GG; Tyler SJ; Bennett GS; Brain SD; Clarke AR; Naylor RL; Wilcock GK; Brady RL; Dawbarn D
    Biochem Biophys Res Commun; 2001 Mar; 282(1):131-41. PubMed ID: 11263982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the recombinant extracellular domain of the neurotrophin receptor TrkA and its interaction with nerve growth factor (NGF).
    Woo SB; Whalen C; Neet KE
    Protein Sci; 1998 Apr; 7(4):1006-16. PubMed ID: 9568907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors.
    Wehrman T; He X; Raab B; Dukipatti A; Blau H; Garcia KC
    Neuron; 2007 Jan; 53(1):25-38. PubMed ID: 17196528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NGF responsiveness in human neuroblastoma.
    Bogenmann E; Peterson S; Maekawa K; Matsushima H
    Oncogene; 1998 Nov; 17(18):2367-76. PubMed ID: 9811468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
    Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
    Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analyses of the kit receptor for the steel factor.
    Blechman JM; Lev S; Givol D; Yarden Y
    Stem Cells; 1993 Jul; 11 Suppl 2():12-21. PubMed ID: 7691317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.